ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Behcet’s syndrome and uveitis"

  • Abstract Number: 1692 • 2019 ACR/ARP Annual Meeting

    Long-Term Follow-Up of Anti-IL6-Receptor Tocilizumab in Refractory Uveitis in Patients with Behçet Disease: Multicenter Study of 14 Patients in Clinical Practice

    Iñigo Gonzalez-Mazon1, Lara Sanchez-Bilbao 2, Belén Atienza-Mateo 2, Jose Luis Martín-Varillas 2, DIANA PRIETO- PENA 1, Vanesa Calvo-Río 3, Rosalia Demetrio 4, Natalia Palmou-Fontana 1, Javier Loricera 5, Emma Beltrán Catalán 6, Marisa Hernández Garfella 7, Elia Valls-Pascual 8, Antonio Atanés 9, Miguel Cordero Coma 9, Joan M Nolla 10, Carmen carrasco-Cubero 11, Julio Sánchez 12, Miguel A Gonzalez-Gay 2 and Ricardo Blanco 2, 1Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 2Rheumatology, Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Hospital Marqués de Valdecilla, Santander, Cantabria, Spain, 4Hospital Universitario Marqués de Valdecilla, Santander, Spain, 5H.U. Marques de Valdecilla, Santander, Spain, 6Hospital del Mar, Barcelona, Spain, 7H.G.U. Valencia, Valencia, 8Dr Peset University Hospital, Valencia, Spain, 9HUAC La Coruña, Coruña, Spain, 10Hospital Universitari de Bellvitge, Hospitalet, Spain, 11CHU de Badajoz, Badajoz, Spain, 12Hospital 12 de Octubre, Madrid, Spain

    Background/Purpose: Ocular involvement in Behçet’s disease (BD) is a potential severe and disabling complication. Anti-TNF-α agents have shown an improvement of visual outcome in BD-related…
  • Abstract Number: 2761 • 2014 ACR/ARHP Annual Meeting

    Increased Risk of Parenchymal Neurological Involvement in Behcet’s Syndrome Patients with Panuveitis

    Berivan Bitik1, Berna Goker2, Kubilay Sahin3, Yesim Sucullu Karadag4, Ridvan Mercan5, Abdurrahman Tufan1, Mehmet Akif Ozturk1, Fikri Ak4, Yasar Karaaslan6,7 and Seminur Haznedaroglu1, 1Internal Medicine-Rheumatology, Gazi University School of Medicine, Ankara, Turkey, 2Department of Internal Medicine- Rheumatology, Gazi University School of Medicine, Ankara, Turkey, 3Rheumatology, Ankara Numune Education and Research Hospital, Ankara, Turkey, 4Neurology, Ankara Numune Education and Research Hospital, Ankara, Turkey, 5Gazi University School of Medicine, Ankara, Turkey, 6Rheumatology, Hitit University, Corum, Turkey, 7Ankara Numune Training and Research Hospital, Ankara, Turkey

    Background/Purpose Behcet’s Syndrome (BS) is a systemic vasculitis which may involve multiple organ systems simultaneously. Most frequently, clinical findings in BS fit into well recognized…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.